Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raed Alroughani

Showing results (91-100 of 223) with videos related to

Pageof 23
Sort By:
Neurology and Therapy|March 16, 2019
An Overview of High-Efficacy Drugs for Multiple Sclerosis: Gulf Region Expert OpinionRaed Alroughani, Jihad Said Inshasi, Dirk Deleu, et al.
Therapeutic Advances in Neurological Disorders|April 29, 2021
The MSBase pregnancy, neonatal outcomes, and women's health registryVilija G Jokubaitis, Olga Skibina, Raed Alroughani, et al.
Journal of the Neurological Sciences|January 3, 2016
JC virus seroprevalence and seroconversion in multiple sclerosis cohort: A Middle-Eastern studyRaed Alroughani, Saeed Akhtar, Samar F Ahmed, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 15, 2016
Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched studyIlya Kister, Tim Spelman, Raed Alroughani, et al.
Multiple Sclerosis International|January 24, 2014
Future of management of multiple sclerosis in the middle East: a consensus view from specialists in ten countriesMohammed Aljumah, Raed Alroughani, I Alsharoqi, et al.
The International Journal of Neuroscience|December 29, 2016
Intervening to reduce the risk of future disability from multiple sclerosis: are we there yet?Maurice Dahdaleh, Raed Alroughani, Mohammed Aljumah, et al.
Therapeutic Advances in Neurological Disorders|September 25, 2020
The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspectiveRaed Alroughani, Bart Van Wijmeersch, Jabber Al Khaboori, et al.
Neurology and Therapy|June 8, 2023
Multicentre Observational Study of Treatment Satisfaction with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in the Arabian Gulf: The CLUE StudyJihad Inshasi, Samar Farouk, Ahmed Shatila, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 14, 2022
Real-world effectiveness and safety profile of teriflunomide in the management of multiple sclerosis in the Gulf Cooperation Council countries: An expert consensus narrative reviewRaed Alroughani, Jihad Inshasi, Mona Al Khawajah, et al.
Multiple Sclerosis and Related Disorders|May 27, 2015
Functional clinical outcomes in multiple sclerosis: Current status and future prospectsRana Karabudak, Maurice Dahdaleh, Mohammed Aljumah, et al.
Pageof 23

Showing results (91-100 of 223) with videos related to

Sort By:
Pageof 23
Neurology and Therapy|March 16, 2019
An Overview of High-Efficacy Drugs for Multiple Sclerosis: Gulf Region Expert OpinionRaed Alroughani, Jihad Said Inshasi, Dirk Deleu, et al.
Therapeutic Advances in Neurological Disorders|April 29, 2021
The MSBase pregnancy, neonatal outcomes, and women's health registryVilija G Jokubaitis, Olga Skibina, Raed Alroughani, et al.
Journal of the Neurological Sciences|January 3, 2016
JC virus seroprevalence and seroconversion in multiple sclerosis cohort: A Middle-Eastern studyRaed Alroughani, Saeed Akhtar, Samar F Ahmed, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 15, 2016
Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched studyIlya Kister, Tim Spelman, Raed Alroughani, et al.
Multiple Sclerosis International|January 24, 2014
Future of management of multiple sclerosis in the middle East: a consensus view from specialists in ten countriesMohammed Aljumah, Raed Alroughani, I Alsharoqi, et al.
The International Journal of Neuroscience|December 29, 2016
Intervening to reduce the risk of future disability from multiple sclerosis: are we there yet?Maurice Dahdaleh, Raed Alroughani, Mohammed Aljumah, et al.
Therapeutic Advances in Neurological Disorders|September 25, 2020
The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspectiveRaed Alroughani, Bart Van Wijmeersch, Jabber Al Khaboori, et al.
Neurology and Therapy|June 8, 2023
Multicentre Observational Study of Treatment Satisfaction with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in the Arabian Gulf: The CLUE StudyJihad Inshasi, Samar Farouk, Ahmed Shatila, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 14, 2022
Real-world effectiveness and safety profile of teriflunomide in the management of multiple sclerosis in the Gulf Cooperation Council countries: An expert consensus narrative reviewRaed Alroughani, Jihad Inshasi, Mona Al Khawajah, et al.
Multiple Sclerosis and Related Disorders|May 27, 2015
Functional clinical outcomes in multiple sclerosis: Current status and future prospectsRana Karabudak, Maurice Dahdaleh, Mohammed Aljumah, et al.
Pageof 23